» Articles » PMID: 23577618

Prolonged Delusional State Triggered by Repeated Ingestion of Aromatic Liquid in a Past 5-methoxy-N, N-diisopropyltryptamine Abuser

Overview
Publisher Biomed Central
Specialty Psychiatry
Date 2013 Apr 13
PMID 23577618
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A 30-year-old Japanese man with no previous psychiatric history presented to our facility with delusions, which had been ongoing for 2 months. Upon further interview, he confided that he had a past history of recurrent 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT or "Foxy") abuse, as well as a recent history of recurrent ingestion of a legal aromatic liquid used as a recreational drug. After this episode, his condition improved and he did not follow up at subsequent appointments. However, 6 months later, he suffered a relapse of prolonged delusions after again ingesting a recreational aromatic liquid. An evaluation of the chronological sequence of the patient's condition revealed that ingestion of these aromatic liquids, which can be purchased easily on the Internet, likely triggered the patient's delusional episodes. We speculate that the patient's recurrent abuse of 5-MeO-DIPT caused sensitization (or reverse tolerance), thus prolonging his delusions. Sensitization is the amplification of a response following repeated administrations of a stimulus. 5-MeO-DIPT is a popular drug of abuse, and it is highly probable that a large number of past 5-MeO-DIPT users are currently sensitized. This is an important latent factor underlying subsequent episode of drug-induced psychosis. Psychiatrists should consider the possibility of 5-MeO-DIPT sensitization when evaluating patients with acute psychoses.

Citing Articles

Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT receptor in the mouse striatum and prefrontal cortex.

Hagino Y, Hall F, Uhl G, Sora I, Ikeda K Neuropsychopharmacol Rep. 2021; 41(1):91-101.

PMID: 33547882 PMC: 8182963. DOI: 10.1002/npr2.12161.


Designer drugs: mechanism of action and adverse effects.

Luethi D, Liechti M Arch Toxicol. 2020; 94(4):1085-1133.

PMID: 32249347 PMC: 7225206. DOI: 10.1007/s00204-020-02693-7.


Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats.

Noworyta-Sokolowska K, Kaminska K, Rzemieniec J, Wnuk A, Wojcieszak J, Gorska A Forensic Toxicol. 2019; 37(1):45-58.

PMID: 30636982 PMC: 6315008. DOI: 10.1007/s11419-018-0433-x.


Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish.

Savoldi R, Polari D, Pinheiro-da-Silva J, Silva P, Lobao-Soares B, Yonamine M Front Behav Neurosci. 2017; 11:139.

PMID: 28804451 PMC: 5532431. DOI: 10.3389/fnbeh.2017.00139.


Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Jiang X, Shen H, Yu A Pharmacol Rep. 2016; 68(3):608-15.

PMID: 26977821 PMC: 4848137. DOI: 10.1016/j.pharep.2016.01.008.


References
1.
Smolinske S, Rastogi R, Schenkel S . Foxy methoxy: a new drug of abuse. J Med Toxicol. 2007; 1(1):22-5. View

2.
Meatherall R, Sharma P . Foxy, a designer tryptamine hallucinogen. J Anal Toxicol. 2003; 27(5):313-7. DOI: 10.1093/jat/27.5.313. View

3.
Kikura-Hanajiri R, Uchiyama N, Goda Y . Survey of current trends in the abuse of psychotropic substances and plants in Japan. Leg Med (Tokyo). 2011; 13(3):109-15. DOI: 10.1016/j.legalmed.2011.02.003. View

4.
Ikeda A, Sekiguchi K, Fujita K, Yamadera H, Koga Y . 5-methoxy-N,N-diisopropyltryptamine-induced flashbacks. Am J Psychiatry. 2005; 162(4):815. DOI: 10.1176/appi.ajp.162.4.815. View

5.
Ujike H, Sato M . Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci. 2004; 1025:279-87. DOI: 10.1196/annals.1316.035. View